Insurers May Be Underpaying Doctors
Practices need to incorporate efforts to double check reimbursement against contracts
WHO Targets for Chronic Hepatitis B Will Be Cost-Effective
Achieving WHO targets for diagnosis, treatment by 2030 will be cost-effective at $103 per QALY
Assessing, Improving Patient Satisfaction Cuts Malpractice Risk
Patient satisfaction can be improved by reducing long wait times, improving communication
Canada Updates Guidelines for Hepatitis C Virus Infection
Recommendations include screening for all born from 1945 to 1975, all-oral treatment regimens
CDC: Salmonella-Tainted Melon Outbreak Appears to Be Over
A total of 77 people were sickened across nine states; 36 were hospitalized
Tools, Methods of RCTs Can Be Adapted to Real-World Settings
3 options described for applying approaches used in randomized controlled trials to real-world data
Guidelines for ART Updated for Those With or at Risk for HIV
ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis
One-Third of Hep C Rx Receive Absolute Denial From Insurers
Both private and public insurers continue to deny coverage for drugs at high rates
WHO: Congo Ebola Outbreak Over
Outbreak was extinguished in less than three months with just 33 deaths
Infection Prevention Staffing Needs May Be Underestimated
Systematic approach needed to determine staffing, coverage needs based on all care settings
